30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q13 Revenue: Mazor Robotics

$4.9MM, +100% (U.S. $4.1MM, +86%; ex-U.S. $0.8MM, +300%)

  • U.S. growth supported by commercial sales of 6 Renaissance units
  • Received 1st orders from distributors in Australia and Taiwan, 2nd order from India
  • To date: 41 units in clinical sites, >4,000 cases, 35,000 implants